WallStreetZenWallStreetZen

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Performance Score
Market Cap
Revenue
EBITDA
Earnings
EPS
Revenue Growth Y/Y
Revenue Growth 5Y
Earnings Growth Y/Y
Earnings Growth 5Y
Earnings Date
AKBA
AKEBIA THERAPEUTICS INC
$241.04M$187.23M$7.34M-$43.03M-$0.23-30.88%-4.40%N/AN/A2024-06-06
INBX
INHIBRX INC
$1.82B$1.78M-$235.69M-$271.16M-$5.4439.30%N/AN/AN/A2024-05-24
ICCC
IMMUCELL CORP
$37.58M$21.28M-$1.17M-$3.90M-$0.5132.89%11.20%N/AN/A
BACK
IMAC HOLDINGS INC
$3.88M-$2.09M-$5.75M-$6.13M-$5.37N/AN/AN/AN/A2024-05-31
APDN
APPLIED DNA SCIENCES INC
$2.47M$5.52M-$11.10M-$12.50M-$17.31-68.52%7.33%N/AN/A2024-06-12
RNAZ
TRANSCODE THERAPEUTICS INC
$7.62M$0.00-$16.43M-$17.06M-$229.08N/AN/AN/AN/A
ADXN
ADDEX THERAPEUTICS LTD
$8.80M$1.83M-$11.01M-$11.73M-$0.1626.20%-22.11%N/AN/A
OMER
OMEROS CORP
$199.91M$0.00-$89.22M-$121.30M-$1.97N/A-100.00%N/AN/A2024-06-06
PMD
PSYCHEMEDICS CORP
$14.98M$21.60M-$970.00k-$4.46M-$0.77-12.18%-12.27%N/AN/A
IKT
INHIBIKASE THERAPEUTICS INC
$11.20M$195.98k-$19.45M-$19.20M-$3.3438.08%N/AN/AN/A2024-06-07
AVTX
AVALO THERAPEUTICS INC
$9.92M$1.45M-$140.24M-$142.88M-$192.60-91.64%-22.31%N/AN/A
CSBR
CHAMPIONS ONCOLOGY INC
$63.89M$49.22M-$7.67M-$9.73M-$0.72-8.29%15.19%N/AN/A
EVAX
EVAXION BIOTECH A
$14.10M$73.00k-$21.23M-$22.13M-$8.10N/AN/AN/AN/A2024-05-29
TRVN
TREVENA INC
$7.43M$3.14M-$35.78M-$40.15M-$2.75N/A-11.35%N/AN/A2024-06-13
MODV
MODIVCARE INC
$390.94M$2.78B-$36.51M-$222.80M-$15.716.78%14.42%N/AN/A
TRIB
TRINITY BIOTECH PLC
$12.11M$56.83M-$11.25M-$24.02M-$3.20-9.10%-10.15%N/AN/A
SNDA
SONIDA SENIOR LIVING INC
$448.33M$260.69M$57.80M-$26.21M-$4.897.71%-10.72%N/AN/A2024-06-04
EYEN
EYENOVIA INC
$40.40M$8.78k-$29.01M-$32.44M-$0.73N/AN/AN/AN/A2024-06-12
AHCO
ADAPTHEALTH CORP
$1.33B$3.25B-$182.87M-$696.74M-$5.207.94%31.51%N/AN/A
CGC
CANOPY GROWTH CORP
$988.59M$246.67M-$907.84M-$952.65M-$16.21-10.51%16.69%N/AN/A2024-05-30
NVOS
NOVO INTEGRATED SCIENCES INC
$9.15M$13.66M-$8.68M-$12.08M-$0.6416.91%8.68%N/AN/A2024-05-24
NXL
NEXALIN TECHNOLOGY INC
$9.74M$158.86k-$4.90M-$4.94M-$0.66-84.56%N/AN/AN/A
GLPG
GALAPAGOS NV
$1.95BN/AN/AN/AN/AN/AN/AN/AN/A
BEAT
HEARTBEAM INC
$54.50M$0.00-$15.11M-$15.11M-$0.59N/AN/AN/AN/A
MREO
MEREO BIOPHARMA GROUP PLC
$448.87MN/AN/AN/AN/AN/AN/AN/AN/A2024-05-23
MGRX
MANGOCEUTICALS INC
$5.98M$844.87k-$9.00M-$9.02M-$0.47670.43%N/AN/AN/A
BHVN
BIOHAVEN LTD
$3.30B$0.00-$512.22M-$517.18M-$6.89N/AN/AN/AN/A
TIVC
TIVIC HEALTH SYSTEMS INC
$2.91M$1.13M-$7.43M-$7.61M-$9.29-36.61%N/AN/AN/A
CCM
CONCORD MEDICAL SERVICES HOLDINGS LTD
$21.82M$74.33M-$1.53M-$41.17M-$0.9411.91%22.37%N/AN/A
CING
CINGULATE INC
$4.85M$0.00-$21.08M-$22.50M-$20.81N/AN/AN/AN/A
UNCY
UNICYCIVE THERAPEUTICS INC
$39.11M$0.00-$36.32M-$37.82M-$1.19N/AN/AN/AN/A
BIVI
BIOVIE INC
$30.02M$0.00-$32.50M-$37.18M-$0.94N/AN/AN/AN/A2024-05-27
IRIX
IRIDEX CORP
$43.23M$49.92M-$8.78M-$10.94M-$0.67-12.86%2.71%N/AN/A
BTCY
BIOTRICITY INC
$9.81M$11.63M-$9.92M-$15.39M-$1.7528.55%121.10%N/AN/A2024-06-28
NERV
MINERVA NEUROSCIENCES INC
$17.62M$0.00-$31.57M-$31.60M-$4.48N/AN/AN/AN/A
SLS
SELLAS LIFE SCIENCES GROUP INC
$84.32M$0.00-$35.26M-$35.81M-$1.10N/AN/AN/AN/A2024-06-20
CTCX
CARMELL CORP
$42.65M$21.92M-$7.51M-$7.67MN/A56.29%N/AN/AN/A
BCAB
BIOATLA INC
$136.17M$0.00-$118.07M-$119.24M-$2.49N/AN/AN/AN/A2024-06-13
ANEB
ANEBULO PHARMACEUTICALS INC
$59.65M$0.00-$9.26M-$9.35M-$0.37N/AN/AN/AN/A
ANGO
ANGIODYNAMICS INC
$241.93M$324.01M-$169.01M-$192.37M-$4.78-3.19%9.57%N/AN/A2024-07-10
EPRX
EUPRAXIA PHARMACEUTICALS INC
$104.73MN/AN/AN/AN/AN/AN/AN/AN/A2024-06-06
CVM
CEL SCI CORP
$68.78M$0.00-$25.22M-$29.95M-$0.63N/A-100.00%N/AN/A
GANX
GAIN THERAPEUTICS INC
$47.48M$0.00-$20.98M-$21.14M-$1.50-100.00%N/AN/AN/A2024-06-24
MGX
METAGENOMI INC
$262.25MN/AN/AN/AN/AN/AN/AN/AN/A
STRM
STREAMLINE HEALTH SOLUTIONS INC
$20.65M$22.60M-$13.34M-$18.70M-$0.33-9.21%0.21%N/AN/A2024-06-12
NRXS
NEURAXIS INC
$20.05M$2.46M-$14.08M-$14.63M-$4.50-8.37%N/AN/AN/A
QTI
QT IMAGING HOLDINGS INC
$19.08M$1.40M-$7.36M-$8.59M-$0.2795.93%N/AN/AN/A
PRFX
PAINREFORM LTD
$1.57M$0.00-$12.72M-$12.54M-$7.66N/AN/AN/AN/A
EVO
EVOTEC SE
$1.86BN/AN/AN/AN/AN/AN/AN/AN/A2024-06-10
INTS
INTENSITY THERAPEUTICS INC
$67.05M$0.00-$13.53M-$15.13M-$2.06N/AN/AN/AN/A
FOXO
FOXO TECHNOLOGIES INC
$2.66M$453.00k-$67.02M-$73.13M-$13.95277.50%N/AN/AN/A2024-05-24
GUTS
FRACTYL HEALTH INC
$338.15MN/AN/AN/AN/AN/AN/AN/AN/A
PHGE
BIOMX INC
$18.72M$0.00-$22.87M-$26.17M-$0.51N/AN/AN/AN/A2024-06-19
VSTM
VERASTEM INC
$291.24M$0.00-$101.16M-$105.52M-$4.41N/A-100.00%N/AN/A
GCTK
GLUCOTRACK INC
$13.70M$0.00-$7.58M-$7.56M-$0.41N/A-100.00%N/AN/A
TLSA
TIZIANA LIFE SCIENCES LTD
$76.70M$0.00-$17.15M-$17.69M-$0.17N/AN/AN/AN/A
ALVO
ALVOTECH
$3.60B$93.38M-$359.68M-$551.73M-$2.439.84%N/AN/AN/A2024-05-21
ZTEK
ZENTEK LTD
$115.99M$24.90k-$8.44M-$8.87M-$0.08-84.61%N/AN/AN/A
APVO
APTEVO THERAPEUTICS INC
$3.26M$0.00-$26.52M-$27.02M-$92.23N/A-100.00%N/AN/A
ACON
ACLARION INC
$2.67M$60.05k-$5.02M-$6.13M-$7.02-21.90%N/AN/AN/A
BDSX
BIODESIX INC
$180.63M$54.85M-$32.10M-$47.06M-$0.5434.70%N/AN/AN/A
INAB
IN8BIO INC
$45.45M$0.00-$28.50M-$31.04M-$0.91N/AN/AN/AN/A
OWLT
OWLET INC
$35.74M$58.02M-$15.16M-$23.69M-$2.85-0.64%N/AN/AN/A2024-06-21
PSTV
PLUS THERAPEUTICS INC
$12.78M$6.08M-$10.73M-$11.77M-$3.04733.42%16.77%N/AN/A
TOVX
THERIVA BIOLOGICS INC
$6.41M$0.00-$19.71M-$19.04M-$1.16N/AN/AN/AN/A2024-05-21
FNCH
FINCH THERAPEUTICS GROUP INC
$3.12M$0.00-$14.28M-$16.28M-$10.14-100.00%N/AN/AN/A
MLEC
MOOLEC SCIENCE SA
$45.08M$2.90M-$6.25M-$6.48M-$0.13N/AN/AN/AN/A2024-05-29
IXHL
INCANNEX HEALTHCARE INC
$39.68MN/AN/AN/AN/AN/AN/AN/AN/A
TELO
TELOMIR PHARMACEUTICALS INC
$182.99MN/AN/AN/AN/AN/AN/AN/AN/A
ELUT
ELUTIA INC
$80.60M$28.99M-$38.19M-$47.68M-$2.32-7.86%N/AN/AN/A
SSKN
STRATA SKIN SCIENCES INC
$13.81M$32.55M-$3.83M-$11.36M-$0.33-11.29%1.24%N/AN/A
ATXI
AVENUE THERAPEUTICS INC
$3.51M$0.00-$7.18M-$7.18M-$7.90N/AN/AN/AN/A2024-06-24
NVST
ENVISTA HOLDINGS CORP
$3.18B$2.56B$143.40M-$120.40M-$0.72-0.08%N/AN/AN/A2024-05-21
COEP
COEPTIS THERAPEUTICS HOLDINGS INC
$12.99M$0.00-$15.03M-$16.31M-$0.54N/AN/AN/AN/A
SAVA
CASSAVA SCIENCES INC
$1.11B$0.00-$46.45M-$47.90M-$1.16N/AN/AN/AN/A
TAK
TAKEDA PHARMACEUTICAL CO LTD
$41.48B$27.12B$6.36B$916.46M$0.29-7.42%8.11%-60.57%-13.81%
NCNA
NUCANA PLC
$8.09M$0.00-$38.43M-$33.25M-$15.94N/AN/AN/AN/A
ACXP
ACURX PHARMACEUTICALS INC
$35.65M$0.00-$16.05M-$16.05M-$1.18N/AN/AN/AN/A
ATNF
180 LIFE SCIENCES CORP
$1.49M$0.00-$18.43M-$16.24M-$29.19N/AN/AN/AN/A
CYH
COMMUNITY HEALTH SYSTEMS INC
$501.67M$12.52B$1.39B-$123.00M-$0.942.57%-1.98%N/AN/A
HUMA
HUMACYTE INC
$753.80M$0.00-$91.50M-$105.70M-$1.00-100.00%N/AN/AN/A2024-06-11
MD
PEDIATRIX MEDICAL GROUP INC
$651.30M$2.00B$18.56M-$70.58M-$0.860.91%3.03%N/AN/A
FGEN
FIBROGEN INC
$119.37M$167.49M-$214.56M-$240.46M-$2.4544.30%-3.95%N/AN/A2024-06-05
NLSP
NLS PHARMACEUTICS LTD
$5.85M$0.00-$12.02M-$12.17M-$0.32N/AN/AN/AN/A
MODD
MODULAR MEDICAL INC
$38.76M$0.00-$16.28M-$16.76M-$0.97N/AN/AN/AN/A2024-06-26
EUDA
EUDA HEALTH HOLDINGS LTD
$57.38M$3.71M-$9.90M-$10.04M-$0.44-1.54%N/AN/AN/A
ABVC
ABVC BIOPHARMA INC
$11.61M$25.36k-$9.22M-$12.62M-$2.25-97.63%N/AN/AN/A2024-05-30
IINN
INSPIRA TECHNOLOGIES OXY BHN LTD
$36.00M$0.00-$11.70M-$11.29M-$0.93N/AN/AN/AN/A
NBY
NOVABAY PHARMACEUTICALS INC
$4.50M$14.23M-$10.95M-$18.55M-$3.485.66%5.19%N/AN/A
CCEL
CRYO CELL INTERNATIONAL INC
$72.94M$31.37M-$11.34M-$9.73M-$1.161.52%0.57%N/AN/A2024-07-12
ASLN
ASLAN PHARMACEUTICALS LTD
$8.29M$12.00MN/A-$35.03M-$1.75N/A31.95%N/AN/A
PTN
PALATIN TECHNOLOGIES INC
$32.27M$5.90M-$32.53M-$32.88M-$2.5152.80%-22.16%N/AN/A
SCNI
SCINAI IMMUNOTHERAPEUTICS LTD
$2.51M$0.00-$5.99M-$6.50M-$1.60N/AN/AN/AN/A
IRWD
IRONWOOD PHARMACEUTICALS INC
$1.03B$413.55M-$977.81M-$1.05B-$6.77-0.86%3.62%N/AN/A
TBRG
TRUBRIDGE INC
$133.71M$336.45M-$19.44M-$51.39M-$3.530.43%3.84%N/AN/A
NVAX
NOVAVAX INC
$1.83B$996.61M-$337.06M-$398.71M-$3.13-26.66%103.41%N/AN/A2024-06-13
MPLN
MULTIPLAN CORP
$379.83M$959.44M$90.63M-$631.60M-$0.98-5.78%N/AN/AN/A2024-05-21
BHC
BAUSCH HEALTH COMPANIES INC
$2.48B$8.97B$2.34B-$455.00M-$1.2310.01%1.31%N/AN/A
TLSI
TRISALUS LIFE SCIENCES INC
$267.52M$21.98M-$63.18M-$63.99M-$2.6768.96%N/AN/AN/A
AKAN
AKANDA CORP
$1.53M$2.16M-$27.74M-$32.28M-$7.16-17.55%N/AN/AN/A

Healthcare Industries

IndustryStocks1d %1w %1m %1y %Zen ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
679-0.70%+1.84%+3.96%-19.69%8.47x6.01x+18.62%+3.83%-27.52%+77.73%Strong Buy
64-0.44%+1.56%+12.99%+11.25%38.96x4.47x-13.18%+6.48%+11.49%+5.02%Buy
18-0.03%+1.66%+7.51%+18.11%31.85x6.42x+33.60%+8.10%+14.22%+11.01%Buy
87-0.75%+1.10%+5.60%-1.99%-1.01x2.20x+12.36%+3.36%+6.05%+32.29%Strong Buy
12+0.52%+1.22%+4.66%+4.46%25.53x3.07x+15.18%+4.74%+11.78%+11.78%Buy
61+0.25%+2.04%-0.03%-19.66%9.15x3.33x+6.71%+2.23%+5.33%+26.88%Buy
51-0.09%+0.01%+4.96%+11.10%39.23x4.59x-92.23%+6.58%+13.66%+15.22%Buy
150-0.35%+1.37%+2.08%-13.46%30.60x4.00x+7.35%+5.26%+8.26%+19.86%Buy
10+0.87%+0.34%+1.16%+26.37%26.84x107.17x-11.87%+3.44%+19.58%+10.98%Buy
56+0.16%+1.85%+6.62%-5.76%59.83x3.64x+11.25%+7.73%+10.05%+18.23%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)


Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 46 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -42.43% over the past year, underperforming other healthcare stocks by -37 percentage points.

Cross Country Healthcare has an average 1 year price target of $19.50, an upside of 33.84% from Cross Country Healthcare's current stock price of $14.57.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the second best healthcare stock with a Zen Score of 67, which is 43 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 14.93% over the past year, overperforming other healthcare stocks by 21 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 44.77% from Corcept Therapeutics's current stock price of $28.09.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Kamada (NASDAQ:KMDA)


Kamada (NASDAQ:KMDA) is the third best healthcare stock with a Zen Score of 65, which is 41 points higher than the healthcare sector average of 24. It passed 20 out of 33 due diligence checks and has strong fundamentals. Kamada has seen its stock return 12.82% over the past year, overperforming other healthcare stocks by 19 percentage points.

Kamada has an average 1 year price target of $11.00, an upside of 104.84% from Kamada's current stock price of $5.37.

Kamada stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Kamada, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Sanofi (NASDAQ:SNY)


Sanofi (NASDAQ:SNY) has an annual dividend yield of 8.1%, which is 6 percentage points higher than the healthcare sector average of 2.05%. Sanofi's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Sanofi's dividend has shown consistent growth over the last 10 years.

Sanofi's dividend payout ratio of 82.1% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)


Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 7.93%, which is 6 percentage points higher than the healthcare sector average of 2.05%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 7.88%, which is 6 percentage points higher than the healthcare sector average of 2.05%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.28% in the last day, and up 1.47% over the last week. Heart Test Laboratories was the among the top losers in the healthcare sector, dropping -38.37% yesterday.

Heart Test Laboratories shares are trading lower after the company's 1-for-100 reverse stock split began trading on a split-adjusted basis.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)


Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -44.03% in the past year. It has underperformed other stocks in the healthcare sector by -38 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -23.81% in the past year. It has underperformed other stocks in the healthcare sector by -18 percentage points.

3. Cross Country Healthcare (NASDAQ:CCRN)


Cross Country Healthcare (NASDAQ:CCRN) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Cross Country Healthcare has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Cross Country Healthcare's stock has dropped -42.43% in the past year. It has underperformed other stocks in the healthcare sector by -37 percentage points.

Are healthcare stocks a good buy now?

50.29% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 32.6% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.53x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.